Skip to content

Digital Support for People With Cognitive Impairment

Digital Support for People With Cognitive Impairment - an Intervention to Increase Occupational Performance and the Possibility to Live a More Independent Life

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04470219
Enrollment
16
Registered
2020-07-14
Start date
2016-10-31
Completion date
2018-02-28
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Cognitive Impairments, Stroke

Keywords

Self-Help Devices, Occupational Therapy

Brief summary

Cognitive impairment may cause problems in planning and initiating daily activities, as well as remembering to do what is scheduled. This study investigates the effectiveness of an interactive web-based mobile reminder calendar, (RemindMe). The calendar sends text messages to the user's mobile phone as support in everyday life, for persons with cognitive impairment due to neurological injury/diagnoses. The study has a randomized controlled trial design with data collection at baseline and at follow-up sessions after two and four months. Data collection started in October 2016 and continued until February 2018. RemindMe may give the needed support to remind the person and thus increase the ability to perform activities and to become independent in everyday life.

Interventions

OTHERCognitive support by RemindMe

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Participants with cognitive impairment after stroke or other neurological diseases/injury * Participants experiencing the need for support in planning, organizing and remembering to do activities in everyday life * Participants having access to a computer and mobile phone/smartphone * Participants having linguistic ability to participate in assessments

Exclusion criteria

* Participants with palliative care needs * Participants with reduced vision and/or hearing loss that affects the ability to use a mobile phone/smartphone * Participants with depression or psychiatric illness

Design outcomes

Primary

MeasureTime frameDescription
Canadian Occupational Performance Measure (COPM)Occupational performance is assessed at baseline. Change from baseline in occupational performance is assessed after two months. And change from baseline after four months.The assessment is used to identify and measure performance and satisfaction with the performance of activities of daily living that are important to the person. Assessment is made on a scale from 1 to 10. 1 is the worst outcome and 10 is the best outcome.
Functional independence measure (FIM)Independence is assessed at baseline. Change from baseline in independence is assessed after two months. And change from baseline after four months.The assessment is used to identify and measure independence in everyday Life activities. Assessment is made on a scale from 1 to 7. 1 is the worst outcome and 7 is the best outcome.

Secondary

MeasureTime frameDescription
EQ-5D-5LHQoL is assessed at baseline. Change from baseline in HQoL is assessed after two months. And change from baseline after four monthsThe assessment is used to assess Health-related Quality of Life (HQoL). Assessment is made on a Visual Analog Scale from 1 to 100. 1 is the worst outcome and 100 is the best outcome.
Psychosocial Impact of Assistive Device Scale (PIADS)The psychosocial impact is assessed at baseline. Change from baseline in psychosocial impact is assessed after two months. And change from baseline after four months.The assessment is used to assess an Assistive Device Psychosocial impact on a person. Assessment is made on a scale from -3 to 3. -3 is the worst outcome, 0 is neutral impact and 3 is the best outcome.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026